Shares of ViroPharma Incorporated VPHM are higher on the session by 3.32%, trading at $17.42.
Overall put volume is now running at 18.81x the daily average, with 52% of all puts traded being purchases on the offer. 1,110 contracts have traded on the session so far.
ViroPharma Incorporated is a global biotechnology company dedicated to the development and commercialization of products that address serious diseases, with a focus on products used by physician specialists or in hospital settings.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in